Loss-of-function ordominant-negative mutations in the PPARG gene in humans (see [5]), and genetically-induced PPARγdeficiency in mice [55, 56] are responsible for lipodystrophic syndromeswith insulin resistance, showing the primarily involvement of PPARγdefects in adipose tissue development and metabolic roles. The gene discussed is PPARG; the disease is Insulin resistance.